Erste Asset Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365K | Hold |
21,700
| – | – | ﹤0.01% | 683 |
|
|
2025
Q1 | $482K | Hold |
21,700
| – | – | 0.01% | 433 |
|
|
2024
Q4 | $577K | Hold |
21,700
| – | – | 0.01% | 429 |
|
|
2024
Q3 | $544K | Hold |
21,700
| – | – | 0.01% | 429 |
|
|
2024
Q2 | $520K | Hold |
21,700
| – | – | 0.01% | 415 |
|
|
2024
Q1 | $737K | Hold |
21,700
| – | – | 0.01% | 395 |
|
|
2023
Q4 | $639K | Hold |
21,700
| – | – | 0.01% | 407 |
|
|
2023
Q3 | $521K | Hold |
21,700
| – | – | 0.01% | 404 |
|
|
2023
Q2 | $690K | Hold |
21,700
| – | – | 0.01% | 392 |
|
|
2023
Q1 | $654K | Hold |
21,700
| – | – | 0.01% | 402 |
|
|
2022
Q4 | $840K | Hold |
21,700
| – | – | 0.02% | 378 |
|
|
2022
Q3 | $1.03M | Buy |
21,700
+6,800
| +46% | +$323K | 0.02% | 354 |
|
|
2022
Q2 | $602K | Hold |
14,900
| – | – | 0.01% | 411 |
|
|
2022
Q1 | $886K | Buy |
14,900
+6,400
| +75% | +$380K | 0.02% | 369 |
|
|
2021
Q4 | $672K | Sell |
8,500
-6,500
| -43% | -$514K | 0.01% | 400 |
|
|
2021
Q3 | $1.31M | Buy |
15,000
+8,500
| +131% | +$742K | 0.03% | 313 |
|
|
2021
Q2 | $720K | Hold |
6,500
| – | – | 0.01% | 376 |
|
|
2021
Q1 | $492K | Sell |
6,500
-8,000
| -55% | -$606K | 0.01% | 386 |
|
|
2020
Q4 | $1.29M | Buy |
+14,500
| New | +$1.29M | 0.04% | 314 |
|